These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 31958079)

  • 1. Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo compared to Histology.
    Tuzzi E; Balla DZ; Loureiro JRA; Neumann M; Laske C; Pohmann R; Preische O; Scheffler K; Hagberg GE
    J Alzheimers Dis; 2020; 73(4):1481-1499. PubMed ID: 31958079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.
    Tiepolt S; Schäfer A; Rullmann M; Roggenhofer E; ; Gertz HJ; Schroeter ML; Patt M; Bazin PL; Jochimsen TH; Turner R; Sabri O; Barthel H
    J Alzheimers Dis; 2018; 64(2):393-404. PubMed ID: 29865069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging beta amyloid aggregation and iron accumulation in Alzheimer's disease using quantitative susceptibility mapping MRI.
    Gong NJ; Dibb R; Bulk M; van der Weerd L; Liu C
    Neuroimage; 2019 May; 191():176-185. PubMed ID: 30739060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
    Cogswell PM; Wiste HJ; Senjem ML; Gunter JL; Weigand SD; Schwarz CG; Arani A; Therneau TM; Lowe VJ; Knopman DS; Botha H; Graff-Radford J; Jones DT; Kantarci K; Vemuri P; Boeve BF; Mielke MM; Petersen RC; Jack CR
    Neuroimage; 2021 Jan; 224():117433. PubMed ID: 33035667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
    Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A
    Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI study.
    Tiepolt S; Rullmann M; Jochimsen TH; Gertz HJ; Schroeter ML; Patt M; Sabri O; Barthel H
    Eur J Radiol; 2020 Oct; 131():109243. PubMed ID: 32916411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
    Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
    J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High resolution anatomical and quantitative MRI of the entire human occipital lobe ex vivo at 9.4T.
    Sengupta S; Fritz FJ; Harms RL; Hildebrand S; Tse DHY; Poser BA; Goebel R; Roebroeck A
    Neuroimage; 2018 Mar; 168():162-171. PubMed ID: 28336427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid Beta-Weighted Cortical Thickness: A New Imaging Biomarker in Alzheimer's Disease.
    Kim CM; Hwang J; Lee JM; Roh JH; Lee JH; Koh JY;
    Curr Alzheimer Res; 2015; 12(6):563-71. PubMed ID: 26027813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo multi-parametric manganese-enhanced MRI for detecting amyloid plaques in rodent models of Alzheimer's disease.
    Kim E; Di Censo D; Baraldo M; Simmons C; Rosa I; Randall K; Ballard C; Dickie BR; Williams SCR; Killick R; Cash D
    Sci Rep; 2021 Jun; 11(1):12419. PubMed ID: 34127752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-high field 7T MRI: a new tool for studying Alzheimer's disease.
    Kerchner GA
    J Alzheimers Dis; 2011; 26 Suppl 3():91-5. PubMed ID: 21971453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR microscopy of human amyloid-β deposits: characterization of parenchymal amyloid, diffuse plaques, and vascular amyloid.
    Nabuurs RJ; Natté R; de Ronde FM; Hegeman-Kleinn I; Dijkstra J; van Duinen SG; Webb AG; Rozemuller AJ; van Buchem MA; van der Weerd L
    J Alzheimers Dis; 2013; 34(4):1037-49. PubMed ID: 23340037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous quantitative susceptibility mapping and Flutemetamol-PET suggests local correlation of iron and β-amyloid as an indicator of cognitive performance at high age.
    van Bergen JMG; Li X; Quevenco FC; Gietl AF; Treyer V; Meyer R; Buck A; Kaufmann PA; Nitsch RM; van Zijl PCM; Hock C; Unschuld PG
    Neuroimage; 2018 Jul; 174():308-316. PubMed ID: 29548847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative MRI susceptibility mapping reveals cortical signatures of changes in iron, calcium and zinc in malformations of cortical development in children with drug-resistant epilepsy.
    Lorio S; Sedlacik J; So PW; Parkes HG; Gunny R; Löbel U; Li YF; Ogunbiyi O; Mistry T; Dixon E; Adler S; Cross JH; Baldeweg T; Jacques TS; Shmueli K; Carmichael DW
    Neuroimage; 2021 Sep; 238():118102. PubMed ID: 34058334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An MRI-Based Atlas for Correlation of Imaging and Pathologic Findings in Alzheimer's Disease.
    Raman MR; Schwarz CG; Murray ME; Lowe VJ; Dickson DW; Jack CR; Kantarci K
    J Neuroimaging; 2016 May; 26(3):264-8. PubMed ID: 27017996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical thickness, brain metabolic activity, and in vivo amyloid deposition in asymptomatic, middle-aged offspring of patients with late-onset Alzheimer's disease.
    Duarte-Abritta B; Villarreal MF; Abulafia C; Loewenstein D; Curiel Cid RE; Castro MN; Surace E; Sánchez SM; Vigo DE; Vázquez S; Nemeroff CB; Sevlever G; Guinjoan SM
    J Psychiatr Res; 2018 Dec; 107():11-18. PubMed ID: 30308328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Detection of Gray Matter Neuropathology in the 3xTg Mouse Model of Alzheimer's Disease with Diffusion Tensor Imaging.
    Snow WM; Dale R; O'Brien-Moran Z; Buist R; Peirson D; Martin M; Albensi BC
    J Alzheimers Dis; 2017; 58(3):841-853. PubMed ID: 28505976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo MRI transverse relaxation in community based older persons with and without Alzheimer's dementia.
    Yu L; Dawe RJ; Buchman AS; Boyle PA; Schneider JA; Arfanakis K; Bennett DA
    Behav Brain Res; 2017 Mar; 322(Pt B):233-240. PubMed ID: 27596378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of amyloid plaques in a mouse model of Alzheimer's disease by phase-contrast X-ray computed tomography.
    Noda-Saita K; Yoneyama A; Shitaka Y; Hirai Y; Terai K; Wu J; Takeda T; Hyodo K; Osakabe N; Yamaguchi T; Okada M
    Neuroscience; 2006; 138(4):1205-13. PubMed ID: 16460878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and Prediction of Early Alzheimer's Disease Using a Machine Learning-based Optimized Combination-Feature Set on Gray Matter Volume and Quantitative Susceptibility Mapping.
    Kim HG; Park S; Rhee HY; Lee KM; Ryu CW; Lee SY; Kim EJ; Wang Y; Jahng GH
    Curr Alzheimer Res; 2020; 17(5):428-437. PubMed ID: 32579502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.